Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
UAE Among First Globally to Approve New Obesity and Hypertension Treatments
The United Arab Emirates is strengthening its global leadership in healthcare innovation…
Mayo Clinic Researchers Link CAR-T Cell Aging to Cancer Relapse
Mayo Clinic researchers have discovered a key reason some cancer patients relapse after…
Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Approval based on NIAGARA Phase III trial results which showed a 32%…
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…
